Endemic fungal infections in solid organ transplant recipients

American Journal of Transplantation

Volumn 9, Issue SUPPL. 4, 2009, Pages

  Proia, L ^a   Miller, R ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Blastomycosis; Coccidioidomycosis; Endemic fungi; Endemic mycoses; Histoplasmosis; Organ transplant transplantation

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CORTICOSTEROID; CYCLOSPORIN; CYTOTOXIC AGENT; ECHINOCANDIN; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MYCOPHENOLIC ACID; POSACONAZOLE; PREDNISONE; PYRROLE DERIVATIVE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VORICONAZOLE;

ADULT RESPIRATORY DISTRESS SYNDROME; BLASTOMYCOSIS; CENTRAL NERVOUS SYSTEM; CLINICAL EVALUATION; CLINICAL FEATURE; COCCIDIOIDOMYCOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG MEGADOSE; DRUG METABOLISM; ENZYME IMMUNOASSAY; EPIDEMIOLOGICAL DATA; GRAFT RECIPIENT; GRAFT REJECTION; HISTOPATHOLOGY; HISTOPLASMOSIS; HOSPITALIZATION; HUMAN; IMMUNODIFFUSION; INCIDENCE; KIDNEY GRAFT; LUNG INFECTION; MYCOSIS; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROLOGY; SOLID ORGAN TRANSPLANTATION; SYMPTOM; THORAX RADIOGRAPHY; TREATMENT DURATION; URINALYSIS;

ANTIFUNGAL AGENTS; HUMANS; MYCOSES; ORGAN TRANSPLANTATION;

EID: 72949086668     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02912.x     Document Type: Review

References (78)

1. Gauthier GM, Safdar N, Klein BS, Andes DR. Blastomycosis in solid organ transplant recipients. Transplant Infect Dis 2007 9 : 310 317.
2. Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transplant Infect Dis 2005 7 : 109 115.
3. nd Annual Meeting of the Infectious Diseases Society of America (Boston). Alexandria, VA : Infectious Diseases Society of America 2004 174.
4. Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin N Am 2003 17 : 113 134.
5. Dworkin MS, Duckro AN, Proia L, Semel JD, Huhn G. The epidemiology of blastomycosis in Illinois and factors associated with death. Clin Infect Dis 2005 41 : e107 e111.
6. Sarosi GA, Davies SF. Blastomycosis: State of the art. Am Rev Respir Dis 1979 120 : 911 938.
7. Crampton TL, Light RB, Berg GM et al. Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba Hospitals. Clin Infect Dis 2002 34 : 1310 1316.
8. Pappas PG, Threlkeld MG, Bedsole GD, Cleveland KO, Gelfand MS, Dismukes WE. Blastomycosis in immunocompromised patients. Medicine (Baltimore) 1993 72 : 311 325.
9. Serody JS, Mill MR, Detterbeck FC, Harris DT, Cohen MS. Blastomycosis in transplant recipients: Report of a case and review. Clin Infect Dis 1993 16 : 54 58.
10. Gray NA, Baddour LM. Cutaneous inoculation blastomycosis. Clin Infect Dis 2002 34 : E44 E49.
11. Bradsher RW, Jr. Pulmonary blastomycosis. Semin Respir Crit Care Med 2008 29 : 174 181.
12. Meyer KC, McManus EJ, Maki DG. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. New Engl J Med 1993 329 : 1231 1236.
13. Pappas PG, Pottage JC, Pottage JC, Powderly WG, Fraser VJ, Stratton CW et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Inter Med 1992 116 : 847 853.
14. Wheat J, Wheat H, Connolly P, Kleiman M, Supparatpinyo K, Nelson K et al. Cross-Reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 1997 24 : 1169 1171.
15. Durkin M, Witt J, LeMonte A, Wheat B, Connolly P. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 2004 42 : 4873 4875.
16. Chapman SW, Dismukes WE, Proia LA et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2008 46 : 1801 1812.
17. Pappas PG, Bradsher RW, Chapman SW et al. Treatment of blastomycosis with fluconazole: A pilot study. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 1995 20 : 267 271.
18. Li RK, Ciblak MA, Nordoff N, Pasarell L, Warnock DW, McGinnis MR. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, coccidioides immitis, and histoplasma capsulatum. Antimicrob Agents Chemother 2000 44 : 1734 1736.
19. Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998 36 : 2950 2956.
20. Nakai T, Uno J, Ikeda F, Tawara S, Nishimura K, Miyaji M. In vitro antifungal activity of micafungin (FK463) against dimorphic fungi: Comparison of yeast-like and mycelial forms. Antimicrob Agents Chemother 2003 47 : 1376 1381.
21. Parish JM, Blair JE. Coccidioidomycosis. Mayo Clin Proc 2008 83 : 343 349.
22. Galgiani JN. Coccidioidomycosis: A regional disease of national importance: Rethinking approaches for control. Ann Inter Med 1999 130 : 293 300.
23. Desai SA, Minai OA, Gordon SM, O'Neil B, Wiedemann HP, Arroliga AC. Coccidioidomycosis in non-endemic areas: A case series. Respir Med 2001 95 : 305 309.
24. Fisher MC, Koenig GL, White TJ, Taylor JW. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia 2002 94 : 73 84.
25. Stevens DA. Coccidioidomycosis. New Engl J Med 1995 332 : 1077 1082.
26. Hirschmann JV. The Early History of Coccidioidomycosis: 1892-1945. Clin Infect Dis 2007 44 : 1202 1207.
27. Cohen IM, Galgiani JN, Potter D, Ogden DA. Coccidioidomycosis in renal replacement therapy. Arch Inter Med 1982 142 : 489 494.
28. Hall KA, Sethi GK, Rosado LJ, Martinez JD, Huston CL, Copeland JG. Coccidioidomycosis and heart transplantation. J Heart Lung Transplant 1993 12 : 525 526.
29. Holt CD, Winston DJ, Kubak B et al. Coccidioidomycosis in liver transplant patients. Clin Infect Dis 1997 24 : 216 221.
30. Blair JE. Coccidioidomycosis in Patients Who Have Undergone Transplantation. Annals of the New York Academy of Sciences 2007 1111 (Coccidioidomycosis Sixth International Symposium): 365-376.
31. Blair JE, Logan JL. Coccidoiodomycosis in solid organ transplantation. Clin Infect Dis 2001 33 : 1536 1544.
32. Wright PW, Pappagianis D, Wilson M et al. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis 2003 37 : 1265 1269.
33. Miller MB, Hendren R, Gilligan PH. posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol 2004 42 : 2347 2349.
34. Valdivia L, Nix D, Wright M et al. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis 2006 12 : 958 962.
35. Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis 2006 42 : 103 107.
36. Blair JE, Douglas DD, Mulligan DC. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transplant Infect Dis 2003 5 : 3 8.
37. Durkin M, Connolly P, Kuberski T et al. Diagnosis of coccidioidomycosis with use of the coccidioides antigen enzyme immunoassay. Clin Infect Dis 2008 47 : e69 e73.
38. Galgiani JN, Ampel NM, Blair JE et al. Coccidioidomycosis. Clin Infect Dis 2005 41 : 1217 1223.
39. Galgiani JN, Catanzaro A, Cloud GA et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis: A randomized, double-blind trial. Ann Inter Med 2000 133 : 676 686.
40. Proia LA, Tenorio AR. Successful use of voriconazole for treatment of coccidioides meningitis. Antimicrob Agents Chemother 2004 48 : 2341 2341.
41. Anstead GM, Corcoran G, Lewis J, Berg D, Graybill JR. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis 2005 40 : 1770 1776.
42. Antony S. Use of the Echinocandins (Caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient. Clin Infect Dis 2004 39 : 879 880.
43. Hsue G, Napier JT, Prince RA, Chi J, Hospenthal DR. Treatment of meningeal coccidioidomycosis with caspofungin. J Antimicrob Chemother 2004 54 : 292 294.
44. Blair JE. Approach to the solid organ transplant patient with latent infection and disease caused by Coccidioides species. Curr Opin Infect Dis 2008 21 : 415 420.
45. Cuellar-Rodriguez J, Avery RK, Lard M et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009 49 : 710 716.
46. Botterel F, Romand S, Saliba F et al. A case of disseminated histoplasmosis likely due to infection from a liver allograft. Eur J Clin Microbiol Infect Dis 1999 18 : 662 664.
47. Limaye AP, Connolly PA, Sagar M et al. Transmission of histoplasma capsulatum by organ transplantation. New Engl J Med 2000 343 : 1163 1166.
48. Wong SY, Allen DM. Transmission of disseminated histoplasmosis via cadaveric renal transplantation: Case report. Clin Infect Dis 1992 14 : 232 234.
49. Wheat LJ, Smith EJ, Sathapatayavongs B et al. Histoplasmosis in renal allograft recipients. Two large urban outbreaks. Arch Inter Med 1983 143 : 703 707.
50. Ram Peddi V, Hariharan S, First MR. Disseminated histoplasmosis in renal allograft recipients. Clin Transplant 1996 10 : 160 165.
51. Davies SF, Sarosi GA, Peterson PK et al. Disseminated histoplasmosis in renal transplant recipients. Am J Surg 1979 137 : 686 691.
52. Doshi M, Katz D, Miller RA. Histoplasmosis among organ transplant recipeints: A nine year experience from an endemic region: Abstract 1112. Am J Transplant 2006 6 : 441 442.
53. Hood AB, Inglis FG, Lowenstein L, Dossetor JB, MacLean LD. Histoplasmosis and thrombocytopenic purpura: Transmission by renal homotransplantation. Can Medl Assoc J 1965 93 : 587 592.
54. Dwyre DM, Bell AM, Siechen K, Sethi S, Raife TJ. Disseminated histoplasmosis presenting as thrombotic microangiopathy. Transfusion 2006 46 : 1221 1225.
55. Odio CM, Navarrete M, Carrillo JM, Mora L, Carranza A. Disseminated histoplasmosis in infants. Pediatric Infectious Diseases J 1999 18 : 1065 1068.
56. Connolly PA, Durkin MM, LeMonte AM, Hackett EJ, Wheat LJ. Detection of histoplasma antigen by a quantitative enzyme immunoassay. Clin Vaccine Immunol 2007 14 : 1587 1591.
57. Wheat LJ. Improvements in diagnosis of histoplasmosis. Expert Opin Biol Ther 2006 6 : 1207 1221.
58. Kauffman CA, Israel KS, Smith JW, White AC, Schwarz J, Brooks GF. Histoplasmosis in immunosuppressed patients. Am J Med 1978 64 : 923 932.
59. Kauffman CA. Diagnosis of histoplasmosis in immunosuppressed patients. Curr Opin Infect Dis 2008 21 : 421 425.
60. Wheat LJ, Freifeld AG, Kleiman MB et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007 45 : 807 825.
61. Perfect JR. Treatment of non-aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis 2005 40 (S6 401 408.
62. Dismukes WE, Bradsher RW, Cloud GC et al. Itraconazole therapy for blastomycosis and histoplasmosis. Am J Med 1992 93 : 489 497.
63. Kohler S, Wheat LJ, Connolly P et al. Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model. Antimicrob Agents Chemother 2000 44 : 1850 1854. (Pubitemid 30422936)
64. Zaoutis TE, Benjamin DK, Steinbach WJ. Antifungal treatment in pediatric patients. Drug Resistance Updates 2005 8 : 235 245.
65. Freifeld A, Proia LA, Andes D. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother 2009 53 : 1648 1651.
66. Connolly P, Wheat LJ, Schnizlein-Bick C et al. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Antimicrob Agents Chemother 2000 44 : 2604 2608. (Pubitemid 30737670)
67. Restrepo A, Tobón A, Clark B et al. Salvage treatment of histoplasmosis with posaconazole. J Infect 2007 54 : 319 327.
68. McKinsey DS, Kauffman CA, Pappas PG et al. Fluconazole therapy for histoplasmosis. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 1996 23 : 996 1001.
69. Vail GM, Young RS, Wheat LJ, Filo RS, Cornetta K, Goldman M. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transplant Infect Dis 2002 4 : 148 151.
70. Itraconazole package insert. In : janssen Pharmaceuticals, April 2008.
71. Saad AH, DePestel DD, Carver PL. Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants. Pharmacotherapy 2006 26 : 1730 1744.
72. Sádaba B, Campanero MA, Quetglas EG, Azanza JR. Clinical relevance of sirolimus drug interactions in transplant patients. Transplant Proc 2005 36 : 3226 3228.
73. Barone JA, Koh JG, Bierman RH, Colaizzi JL, Swanson KA, Gaffar MC et al. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers. Antimicrob Agents Chemother 1993 37 : 778 784.
74. Stein AG, Daneshmend TK, Warnock DW, Bhaskar N, Burke J, Hawkey CJ. The effects of H2-receptor antagonists on the pharmacokinetics of itraconazole, a new oral antifungal. Br J Clin Pharmacol 1989 27 : 105 106.
75. Jaruratanasirikul S, Sriviriyajan S. Effect of omeprazole on the pharmacokinetics of itraconazole. Eur J Clin Pharmacol 1998 54 : 159 161.
76. Jaruratanasirikul S, Kleepkaew A. Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole. Eur J Clin Pharmacol 1997 52 : 235 237. (Pubitemid 27278380)
77. Barone JA, Moskovitz BL, Guarnieri J et al. Enhanced bioavailability of itraconazole in hydroxypropyl ß-cyclodextrin solution versus capsules in healthy volunteers. Antimicrob Agents Chemother 1998 42 : 1862 1865.
78. Poirier M, Cheymol G. Optimisation of itraconazole therapy using target drug concentrations. Clin Pharmacokinet 1998 35 : 461 473.